Pharmaceutical composition for maintaining and/or reestablishing a rate of blood platelet aggregation clone to the normal value

摘要

The invention relates to a pharmaceutical composition which can be administered to man or animals, for maintaining and/or reestablishing a rate of blood platelet aggregation close to the normal value, which comprises cysteine and/or cystine and/or their derivatives at a dose and in a form which are physiologically acceptable.